HER2-low-positive and response to NACT and prognosis in HER2-negative non-metastatic BC. Li JJ, Yu Y, Ge J. Breast Cancer 2023;30:364-378.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li JJ, Yu Y, Ge J. HER2-low-positive and response to NACT and prognosis in HER2-negative non-metastatic BC. Breast Cancer 2023;30:364-378.
PMID: 36656510